2 completed, 1 recruiting, 1 suspended. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Recruiting 1, Suspended 1 |
| Phase 2 | 3 | Completed 2, Recruiting 1 |
Follow Rectum Cancer: new trials by email Literature Review of Rectum Cancer trials Research Report on Rectum Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamide, Fludarabine - Colorectal Cancer, Colon Cancer | Phase 1 / Phase 2 | Recruiting | Essen Biotech | 85 | 2024-09-29 | 2024-11-05 |
| Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Vactosertib, Fludarabine Phosphate, Cyclophosphamide - Colorectal Cancer, Hematologic Malignancy | Phase 1 | Suspended | David Wald | 12 | 2022-09-09 | 2026-07-14 |
| Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas SGM-101 - Colon Cancer, Rectum Cancer | Phase 1 / Phase 2 | Completed | Surgimab | 75 | 2016-01-01 | 2019-07-18 |
| Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum Cancer Rapamycin - Rectum Cancer | Phase 1 / Phase 2 | Completed | Maastricht Radiation Oncology | 44 | 2006-09-01 | 2019-03-18 |
Colorectal Neoplasms (4) · Rectal Neoplasms (4) · Colonic Neoplasms (2) · Esophageal Neoplasms (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Pancreatic Neoplasms (1)
Colonic Diseases (4) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Gastrointestinal Diseases (4) · Gastrointestinal Neoplasms (4) · Intestinal Diseases (4) · Intestinal Neoplasms (4) · Neoplasms by Site (4) · Rectal Diseases (4) · Neoplasms (3) · Blood Protein Disorders (1) · Bone Marrow Diseases (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Disease Attributes (1)
Cyclophosphamide (2) · Interleukin-2 (2) · IL32 protein, human (1) · Sirolimus (1) · aldesleukin (1) · fludarabine (1) · fludarabine phosphate (1) · pembrolizumab (1) · vactosertib (1)
David Wald (1) · Essen Biotech (1) · Maastricht Radiation Oncology (1) · Surgimab (1)
Netherlands (2) · China (1) · United States (1)
Alexander L Vahrmeijer, MD, PhD (1) · Benjamin Tomlinson, MD (1) · Jeroen Buijsen, MD PhD (1)